Eversource Energy ES Q1 2026 Earnings EPS Misses Estimates Stock Inches Higher Ovid Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Supports Biotechs Cash Discipline XPEL Q1 2026 Earnings EPS Slightly Exceeds Estimates Shares Gain Ground CBIO Q1 2026 Earnings Narrowed Loss Beats Estimates as Clinical Pipeline Progresses REX Q3 2001 Earnings EPS Surpasses Estimates by 23 Alamo Group Q1 2026 Earnings Strong EPS Beat Amid Steady Operational Execution